Buckingham Research Initiates Jazz Pharmaceuticals With Buy
July 23, 2014 at 07:16 AM EDT
Analysts at Buckingham Research initiated coverage on Jazz Pharmaceuticals plc (NASDAQ: JAZZ) with a Buy rating. The target price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.